Thu, April 1, 2021
Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021
Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021

Thomas Shrader Maintained (BCAB) at Strong Buy with Increased Target to $87 on, Mar 26th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-87-on-mar-26th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Thomas Shrader of BTIG, Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Increased Target from $47 to $87 on, Mar 26th, 2021.

Thomas has made no other calls on BCAB in the last 4 months.



There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Thomas


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $45 on, Monday, January 11th, 2021
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $51 on, Monday, January 11th, 2021
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $49 on, Monday, January 11th, 2021

Publication Contributing Sources